Spots Global Cancer Trial Database for gastrointestinal
Every month we try and update this database with for gastrointestinal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation | NCT05659576 | Radiation Esoph... | Sucralfate Usual Care One consent Two consent | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | NCT00001569 | Carcinoma Peritoneal Neop... | Cisplatin Paclitaxel 5-FU | - | National Institutes of Health Clinical Center (CC) | |
| Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy | NCT04957511 | Gynecologic Can... Immunotherapy Gut Microbiome | 18 Years - | Viome | ||
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Natural History of Familial Carcinoid Tumor | NCT00646022 | Carcinoid | [18F]-DOPA | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery | NCT00985400 | Colorectal Canc... | Exercise Progra... Telephone-based... Counseling inte... Questionnaire a... Relaxation Prog... | 18 Years - | M.D. Anderson Cancer Center | |
| Proton Therapy With Capecitabine for Rectal Cancer | NCT00503932 | Rectal Cancer | Proton Therapy Capecitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery | NCT00833859 | Pancreatic Neop... | GTX (gemcitabin... stereotactic bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers | NCT01121939 | Neuroendocrine ... | Bevacizumab Pertuzumab Sandostatin LAR... | 18 Years - | SCRI Development Innovations, LLC | |
| Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers | NCT05153304 | Cancer of Gastr... | personalized va... Nivolumab | 18 Years - | University of California, San Diego | |
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00241722 | Bowel Dysfuncti... Constipation | Alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors | NCT00660426 | Advanced Gastro... Solid Tumors | Oxaliplatin Gemcitabine Capecitabine | 18 Years - | Washington University School of Medicine | |
| Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) | NCT01524783 | Advanced NET of... Advanced NET of... Neuroendocrine ... | Everolimus Placebo Best suportive ... | 18 Years - | Novartis | |
| Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer | NCT04163900 | Biliary Tract C... | NUC-1031 Gemcitabine Cisplatin | 18 Years - | NuCana plc | |
| Development of Early Detection Signs for Gastrointestinal Cancer | NCT00633334 | GI Cancer | Specimen bank | 18 Years - | University of Pittsburgh | |
| Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers | NCT01121939 | Neuroendocrine ... | Bevacizumab Pertuzumab Sandostatin LAR... | 18 Years - | SCRI Development Innovations, LLC | |
| Dose-Finding Study of E7070 in Combination With Irinotecan | NCT00060567 | Cancer | E7070 + irinote... Irinotecan + E7... Irinotecan + E7... | 18 Years - | Eisai Inc. | |
| Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors | NCT01455311 | Pancreatic Tumo... | EUS Guided Fine... EUS Guided Echo... | 18 Years - 85 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei | NCT01946854 | Gastrointestina... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Natural History of Familial Carcinoid Tumor | NCT00646022 | Carcinoid | [18F]-DOPA | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. | NCT01289028 | Gastrointestina... | Nilotinib | 18 Years - | Novartis | |
| Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers | NCT04692454 | Hepatocellular ... Gastrointestina... Immunosuppressi... | Modern acupunct... | 20 Years - 75 Years | Taipei Medical University WanFang Hospital | |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00259922 | Bowel Dysfuncti... Constipation | Placebo Alvimopan Alviompan | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Expression and Function of the Renin-Angiotensin System in the Esophagus | NCT02879721 | Barrett's Esoph... | Candesartan Enalapril | 20 Years - 80 Years | Göteborg University | |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Use of DRS Probe and Tracking for In-vivo Application | NCT05830292 | Gastrointestina... | Diffuse reflect... | 18 Years - 99 Years | Imperial College London | |
| GastroIntestinal Cancer in Children and Adolescents | NCT05693519 | Gastrointestina... Colorectal Canc... Gastric Cancer Hepatoblastoma Hepatocellular ... Burkitt Lymphom... Neuroendocrine ... | 0 Years - 24 Years | Leiden University Medical Center | ||
| Effects of Sarcopenia on Early Postoperative Outcomes in Patients Undergoing Surgical Treatment for Gastric Cancer | NCT03958032 | Gastric Cancer Sarcopenia Malnutrition; C... Complication | No intervention | 18 Years - | Karadeniz Technical University | |
| Natural History of Familial Carcinoid Tumor | NCT00646022 | Carcinoid | [18F]-DOPA | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers | NCT05153304 | Cancer of Gastr... | personalized va... Nivolumab | 18 Years - | University of California, San Diego | |
| Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer | NCT01831609 | Sarcoma | - | Samsung Medical Center | ||
| SCRI Tissue Testing Registry | NCT00965861 | Melanoma Myelodysplastic... Multiple Myelom... Lymphoma | Tissue Registry... | 18 Years - | SCRI Development Innovations, LLC | |
| (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors | NCT05208047 | Advanced Gastro... Metastatic Canc... | CGT9486 plus su... CGT9486 Sunitinib Sunitinib | 18 Years - | Cogent Biosciences, Inc. | |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | NCT00001569 | Carcinoma Peritoneal Neop... | Cisplatin Paclitaxel 5-FU | - | National Institutes of Health Clinical Center (CC) | |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations | NCT05199584 | Solid Tumors Wi... | ENV-101 (talade... | 18 Years - | Endeavor Biomedicines, Inc. | |
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00241722 | Bowel Dysfuncti... Constipation | Alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers | NCT04692454 | Hepatocellular ... Gastrointestina... Immunosuppressi... | Modern acupunct... | 20 Years - 75 Years | Taipei Medical University WanFang Hospital | |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00259922 | Bowel Dysfuncti... Constipation | Placebo Alvimopan Alviompan | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors | NCT01455311 | Pancreatic Tumo... | EUS Guided Fine... EUS Guided Echo... | 18 Years - 85 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| DIBH Proton Planning | NCT01386697 | Lung Cancer Breast Cancer Gastrointestina... Lymphomatous Ma... | 18 Years - | Abramson Cancer Center at Penn Medicine | ||
| Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00256932 | Bowel Dysfuncti... Constipation | alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma | NCT00338988 | Cancer of the G... Cancer of the B... | Capecitabine Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery | NCT00833859 | Pancreatic Neop... | GTX (gemcitabin... stereotactic bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Dose-Finding Study of E7070 in Combination With Irinotecan | NCT00060567 | Cancer | E7070 + irinote... Irinotecan + E7... Irinotecan + E7... | 18 Years - | Eisai Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
